GNC Preventive Nutrition Brain Health Formula with Clinically Studied Ingredients​   Memory Function & Nervous System Health: • Provides choline, huperzine A and tyrosine to promote key neurotransmitters. Plus it has ginkgo biloba to support memory function and mental sharpness. Phosphatidylserine and vitamins B-6 and B-12 help to maintian nervous system health.*  Blood Flow Support: • Contains nutrients to support healthy blood flow, which is vital forbrain health, including resVida, clinically shown to enhance blood vessel dilation.Ginkgo biloba also supports peripheral blood flow. • Clinically studied ingredients • Support memory function & enhance circulation • Helps preserve key neurotransmitters ^In a randomized, double-blind, placebo controlled crossover study, 19 volunteers consumed 3 doses of resVida (30 mg, 90 mg, 270 mg) and a placebo at weekly intervals. Flow-mediated dilatation (FMD) of the brachial artery was measured one hour after ingestion of each treatment and was significantly increased at all 3 doses relative to placebo. 30 mg of resVida demonstrated 2.5% greater increase in FMD relative to placebo.

GNC Preventive Nutrition Brain Health Formula with Clinically Studied Ingredients​   Memory Function & Nervous System Health: • Provides choline, huperzine A and tyrosine to promote key neurotransmitters. Plus it has ginkgo biloba to support memory function and mental sharpness. Phosphatidylserine and vitamins B-6 and B-12 help to maintian nervous system health.*  Blood Flow Support: • Contains nutrients to support healthy blood flow, which is vital forbrain health, including resVida, clinically shown to enhance blood vessel dilation.Ginkgo biloba also supports peripheral blood flow. • Clinically studied ingredients • Support memory function & enhance circulation • Helps preserve key neurotransmitters ^In a randomized, double-blind, placebo controlled crossover study, 19 volunteers consumed 3 doses of resVida (30 mg, 90 mg, 270 mg) and a placebo at weekly intervals. Flow-mediated dilatation (FMD) of the brachial artery was measured one hour after ingestion of each treatment and was significantly increased at all 3 doses relative to placebo. 30 mg of resVida demonstrated 2.5% greater increase in FMD relative to placebo.